Advances in diagnostics for microbial agents: Can clinical validation keep pace with the technical promises?

Annali dell'Istituto Superiore di Sanita

Volumn 45, Issue 2, 2009, Pages 168-172

  Giocoli, Giuseppe ^a,e   Biesheuvel, Cornelis J ^b   Gidding, Heather F ^c   Andresen, David ^d  

^a Associazione Microbiologi Clinici Italiani   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e NONE   (Italy)

Author keywords

Diagnostic tests; Laboratory techniques and procedures; Microbiology; Sensitivity and specificity; Translational medicine

Indexed keywords

ARTICLE; HUMAN; INFECTION; MICROBIOLOGY; STANDARD; STATISTICS; TREATMENT OUTCOME;

HUMANS; INFECTION; MICROBIOLOGY; REFERENCE STANDARDS; TREATMENT OUTCOME;

EID: 69249094578     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fryback D, Thornbury J. The efficacy of diagnostic imaging. Med Decis Making 1991; 11: 88-94.
2. Price C P. Evidence-based laboratory medicine: Supporting decision-making. Clin Chem 2000; 46: 1041-50.
3. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the StarD initiative. Clin Chem 2003; 49: 1-6.
4. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003; 49: 7-18.
5. Smidt N, Overbeke J, de Vet H, Bossuyt P. Endorsement of the STARD Statement by biomedical journals: survey of Instructions to authors (Letter). Clin Chem 2007; 53: 1983-4.
6. Gilligan PH. Impact of clinical practice guidelines on the clinical microbiology laboratory. J Clin Microbiol 2004; 42: 1391-95.
7. Bossuyt PM, Irwig L, Craig J, Glasziou P. Comparative accuracy: assessing new tests against existing diagnostic pathways. Brit Med J 2006; 332: 1089-92.
8. Van den Bruel A, Cleemput I, Aertgeerts B, Aamaekers D, Buntinx F. The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed. J Clin Epidemiol 2007; 11: 1116-22.
9. Sackett DL, Haynes RB. The architecture of diagnostic research. Brit Med J 2002; 324: 539-41.
10. Knottnerus JA, van Weel C, Muris J W. Evaluation of diagnostic procedures. Brit Med J 2002; 324: 477-80.
11. Moons KG, Biesheuvel CJ, Grobbee DE. Test research versus diagnostic research. Clin Chem 2004; 50: 473-6.
12. Weijnen CF, Numans ME, de Wit NJ, Smout AJP, Moons KGM, Verheij TJM, et al. Testing for Helicobacter pylori in dyspeptic patients suspected of peptic ulcer disease in primary care: cross sectional study. Brit Med J 2001; 323: 71-5.
13. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396-402.
14. Rutjes AW, Reitsma JB, Coomarasamy A, Khan KS, Bossuyt PM. Evaluation of diagnostic tests when there is no gold standard. a review of methods. Health Technol Assess 2007; 11: 1-72.
15. Hadgu A, Dendukuri N, Hilden J. Revaluation of nucleic acid amplification tests in the absence of a perfect gold-standard test: a review of the statistical and epidemiologic issues. Epidemiology 2005; 16: 604-12.
16. Sarmiento OL, Weigle KA, Alexander J, Weber DJ, Miller WC. Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J Clin Microbiol 2003; 41: 3233-40.
17. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, et al. Comparison of t-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-73.
18. Biesheuvel CJ, Grobbee DE, Moons KGM. Distraction from randomization in diagnostic research. Ann Epidemiol 2006; 16: 540-44.
19. Lord SJ, Irwig L, Simes rJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med 2006; 144: 850-5.
20. Ritchie K, Bradbury I, Craig J, Eastgate J, Foster L, Kohli H, et al. The clinical and cost effectiveness of screening for meticillin-resistant Staphylococcus aureus (MRSA). NHS Quality Improvement Scotland - October 2007. (Health technology assessment report 9).
21. Inglis TJJ. Principia aetiologica: taking causality beyond Koch's postulates. J Med Microbiol 2007;56,1419-22.
22. Bagos PG, Nikolopoulos G, Ioannidis a. Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler 2006;12:397-411.
23. Cochrane Handbook for Diagnostic test accuracy reviews. available at: http://srdta.cochrane.org/en/index.html.
24. Bossuyt X, Verweire K, Blanckaert N. Laboratory medicine: challenges and opportunities. Clin Chem 2007; 53: 1730-3.